{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T06:17:35Z","timestamp":1788675455510,"version":"build-2803163510"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,3]]},"DOI":"10.7759\/cureus.81636","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T07:24:52Z","timestamp":1743665092000},"source":"Crossref","is-referenced-by-count":3,"title":["Dupilumab-Induced Psoriasis in a Patient With Prurigo Nodularis: A Case Report"],"prefix":"10.7759","author":[{"given":"Hiroki","family":"Ogawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Dupilumab (Dupixent): an interleukin-4 receptor antagonist for atopic dermatitis","volume":"43","author":"D'Ippolito D","year":"2018","unstructured":"D'Ippolito D, Pisano M. Dupilumab (Dupixent): an interleukin-4 receptor antagonist for atopic dermatitis. P T. 2018, 43:532-5.","journal-title":"P T"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1159\/000530608","article-title":"Dupilumab-associated psoriasis and psoriasiform manifestations: a scoping review","volume":"239","author":"Su Z","year":"2023","unstructured":"Su Z, Zeng YP. Dupilumab-associated psoriasis and psoriasiform manifestations: a scoping review. Dermatology. 2023, 239:646-57. 10.1159\/000530608","journal-title":"Dermatology"},{"key":"ref3","article-title":"Prurigo nodularis","author":"Mullins TB","year":"2024","unstructured":"Mullins TB, Sharma P, Riley CA, Syed HA, Sonthalia S. Prurigo nodularis. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02320-9","article-title":"Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials","volume":"29","author":"Yosipovitch G","year":"2023","unstructured":"Yosipovitch G, Mollanazar N, St\u00e4nder S, et al.. Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials. Nat Med. 2023, 29:1180-90. 10.1038\/s41591-023-02320-9","journal-title":"Nat Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-021-00505-z","article-title":"Efficacy and safety of dupilumab in clinical practice: one year of experience on 165 adult patients from a tertiary referral centre","volume":"11","author":"Napolitano M","year":"2021","unstructured":"Napolitano M, Ferrillo M, Patruno C, Scalvenzi M, D'Andrea M, Fabbrocini G. Efficacy and safety of dupilumab in clinical practice: one year of experience on 165 adult patients from a tertiary referral centre. Dermatol Ther (Heidelb). 2021, 11:355-61. 10.1007\/s13555-021-00505-z","journal-title":"Dermatol Ther (Heidelb)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25105164","article-title":"Prurigo nodularis: pathogenesis and the horizon of potential therapeutics","volume":"25","author":"Yook HJ","year":"2024","unstructured":"Yook HJ, Lee JH. Prurigo nodularis: pathogenesis and the horizon of potential therapeutics. Int J Mol Sci. 2024, 25:5164. 10.3390\/ijms25105164","journal-title":"Int J Mol Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/2050313X251317811","article-title":"Dupilumab-induced psoriasis in a patient with atopic dermatitis successfully treated with Upadacitinib: a case report","volume":"13","author":"Cirone KD","year":"2025","unstructured":"Cirone KD, Lovegrove FE. Dupilumab-induced psoriasis in a patient with atopic dermatitis successfully treated with Upadacitinib: a case report. SAGE Open Med Case Rep. 2025, 13:2050313X251317811. 10.1177\/2050313X251317811","journal-title":"SAGE Open Med Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.37992","article-title":"Dupilumab-induced scalp psoriasis in a patient with prurigo nodularis: a case report","volume":"15","author":"Al Hawsawi K","year":"2023","unstructured":"Al Hawsawi K, AlDoboke AW, Alsulami SA, Alamri GE, Alsufi RF. Dupilumab-induced scalp psoriasis in a patient with prurigo nodularis: a case report. Cureus. 2023, 15:e37992. 10.7759\/cureus.37992","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/343899-dupilumab-induced-psoriasis-in-a-patient-with-prurigo-nodularis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T07:25:05Z","timestamp":1743665105000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/343899-dupilumab-induced-psoriasis-in-a-patient-with-prurigo-nodularis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.81636","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,3]]}}}